We subsequently tested irradiated (35 Gray) Id2-kd N2a cells as a whole tumor cell vaccine antigen source in combination with anti-CTLA-4 antibody against AgN2a (Fig 3A) and found that 60% of mice eradicated established tumors (Fig 4D). The gene discussed is CTLA4; the disease is neoplasm.